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Summary 
This article argues that the health-related Millennium Development Goals do not 
appropriately address the challenges faced by the countries of Eastern Europe and Central 
Asia.  By ignoring adult mortality, their achievement would result in relatively small 
gains in life expectancy.  To achieve greater impact, policies in this region must 
supplement the classical Millennium Development Goals with indicators of adult health, 
in particular cardiovascular diseases and external causes of death.  In addition, countries, 
with support from the international community, must improve the quality of vital 
registration data to enable more accurate estimation of the disease burden. 
 
1 Introduction 
This paper examines the application of the health-related Millennium Development Goals 
(MDGs) to the countries of Eastern Europe and Central Asia.  The MDGs originated 
from the United Nations Millennium Declaration in September 2000.  They reflect key 
aims from various UN development conferences in the 1990s and build on the 
International Development Goals developed by the Organization for Economic Co-
operation and Development (OECD) in 1996, including all but one of the OECD Goals 
(UNDP 2003).  The MDGs are now widely accepted as a framework for measuring 
development progress and have become a central focus of development assistance of 
bilateral and multilateral institutions.  
The overall aim of the MDGs is to reverse the spread of poverty and disease by 2015.  
The eight goals are backed by a plan of action that sets out 18 quantifiable targets, each 
using specified indicators.  Three goals and four targets are directly related to health.  
Goal 4 is to reduce child mortality.  The related target is to reduce the under-five 
mortality rate by two-thirds, between 1990 and 2015.  Goal 5 is the improvement of 
maternal health, with the target of reducing the maternal mortality rate by three-quarters, 
between 1990 and 2015.  Goal 6 calls for combating HIV/AIDS, malaria and other 
diseases.  The related targets are to have halted by 2015 and begun to reverse the spread 
of HIV/AIDS, and to have halted by 2015 and begun to reverse the incidence of malaria 
and other major diseases (The World Bank Group 2003; UNDP 2003). 
Our analysis looks at the impact of four scenarios on life expectancy at birth: 
1) achieving the targets set out in the MDGs for infant, child (1-4 years) and 
maternal mortality;  
2) reducing infant, child and maternal mortality to European Union levels (as an 
indicator of the situation in a part of Europe to which countries in this region often 
aspire);  
3) reducing infant, child and maternal mortality to the lowest current levels in the 
sub-region (as an indication of what is arguably achievable now);  
4) reducing deaths from cardiovascular disease and external causes of death to 
European Union levels (as an example of a strategy that would move on from the 
current MDGs to focus on major causes of adult mortality). 
The MDGs focus the attention of the international community on important indicators of 
development (UNDP 2003; Haines and Cassels 2004).  However, they are more relevant 
for some countries or regions than for others.  We argue that the choice of MDGs and 
their corresponding targets focus on sub-Saharan Africa in two important ways.  The 
major reason is that rates of under-five mortality, maternal mortality, and HIV/AIDS 
infection rates are the highest in the world and progress in reducing these rates have so 
far been very limited (UNDP 2003).  The second reason is that, unlike other health 
problems, these are more easily visible.  The 2000 World Health Report, for example, 
used childhood mortality to assess equity of outcome in its measure of health care system 
performance, because these data were much more widely available than data on adult 
mortality (WHO 2000).  Data on infant, maternal, and to a lesser extent childhood 
mortality are collected in many developing countries either by means of routine 
collection systems or intermittent surveys, in particular the series of Demographic and 
Health Surveys.  With the exception of some innovative sentinel programmes (Garenne, 
Kahn et al. 2000) and the recently established Indepth Network (www.indepth-
network.org), much less systematic recording of adult mortality exists.  As a 
consequence, estimated life expectancy at birth is derived by means of modeling 
techniques, in which available information is applied to standard life tables (Coale and 
Demeny 1966).   
The choice of more readily available measures of childhood and maternal mortality as 
indicators of development is influenced by the view that they will broadly reflect the 
overall health of a population.  Yet in those settings in the developing world where adult 
mortality has been studied it has also been found to be very high, especially from 
cardiovascular diseases and injuries (Garenne, Kahn et al. 2000; Walker, McLarty et al. 
2000; Moshiro, Mswia et al. 2001).  However this burden of avoidable disease remains 
largely invisible and has so far not been adequately used to monitor health trends.    
In the former Soviet bloc the situation is different in both aspects.  First of all, premature 
mortality is driven by deaths in adulthood.  Childhood and maternal mortality, while still 
much higher than in advanced industrialized countries, have been reduced in the decades 
following the Second World War, although maternal mortality has increased again in 
many places after 1990.  Furthermore, comprehensive systems to monitor vital statistics 
were put in place, which, although flawed, make it possible to measure and track adult 
mortality in a way that is not easily possible in sub-Saharan Africa.   
Concerns have therefore been raised as to whether the health-related MDGs are 
appropriate for the transition countries of Eastern Europe and Central Asia, as they focus 
attention on childhood and maternal mortality and exclude general adult mortality.  Our 
previous analysis of life expectancy in Russia argued that the health-related International 
Development Targets had limited relevance for Russia.  The analysis covered the 
population of the Russian Federation in 1995-1999 and used life expectancy as the 
measure of population health.  A reduction of infant and child mortality rates by two-
thirds and maternal mortality rates by three-quarters was found to result in an overall 
increase of only 0.96 years in life expectancy at birth.  In contrast, a 20% reduction in 
adult mortality would have resulted in an increase of 1.86 years in male life expectancy.  
A further analysis looked at the effect of narrowing the east-west gap in Europe; a 
reduction of adult mortality to British levels for cardiovascular diseases and external 
causes of death resulted in an increase in life expectancy at birth of 5.97 years for both 
sexes (Lock, Andreev et al. 2002).   
Apart from this analysis on Russia, surprisingly little has been published on the 
appropriateness of global development targets for health in Eastern Europe and Central 
Asia.  Our search using PubMed/Medline in June 2003 could not identify any other 
publication on the subject.  Nevertheless, the situation is likely to be similar in many 
other Eastern European transition countries.  In these countries, under-five and maternal 
mortality are much lower than in countries at similar levels of economic development in 
other parts of the world.  Adult mortality, on the other hand, contributes most to the 
burden of disease and premature mortality.  Deaths due to cardiovascular diseases exceed 
the European Union average in all countries of Eastern Europe and Central Asia, reaching 
levels of 807 per 100,000 population in the Russian Federation in 2001, as compared to a 
European Union level of 258 per 100,000 in 1999, with higher levels among males than 
among females (WHO/Europe 2003).  Deaths due to external causes (injuries, poisoning, 
homicide and suicide) are also much higher than in the European Union prior to 
enlargement in 2004 (EU-15), in particular among men and in some countries of the 
former Soviet Union.  In the Russian Federation in 2001, deaths due to external causes 
numbered 224 per 100,000, compared to a EU-15 level of 40 per 100,000 in 1999 
(WHO/Europe 2003).  The rates of homicide and intentional injury among males in 1999 
were 32 times higher in the Russian Federation than in the EU-15 (WHO/Europe 2003). 
Some other elements of the MDGs may be more applicable to Eastern Europe and 
Central Asia.  The rapid spread of HIV/AIDS and the re-emergence of tuberculosis are 
two major threats to health in this region, particularly in the countries of the former 
Soviet Union.  This highlights the relevance of Millennium Development Goal 6, 
concerned with the spread of HIV/AIDS, malaria and other diseases (including 
tuberculosis).  However, the impact on mortality and thus life expectancy at birth of these 
diseases is still relatively low when compared with non-communicable diseases and 
external causes of death, although this may change in the near future.  Given the large 
and increasing number of HIV infections and the very limited availability of antiretroviral 
treatment, it is clear that the HIV epidemic in Eastern Europe and Central Asia, in 
particular in Russia and Ukraine, may have a devastating impact on mortality patterns in 
the near future, especially when combined with the growth in tuberculosis.  A recent 
World Bank study predicted an increase in the cumulative number of HIV-infected 
individuals in Russia in an “optimistic scenario” from 1.2 million in 2005 to 2.3 million 
in 2010 and 5.4 million in 2020.  Mortality rates would increase from 500 per month in 
2005 to 21,000 per month in 2020 (Rühl, Pokrovsky et al. 2002).  On the basis of the 
2001 life table, this increase in mortality would result in a decrease in life expectancy in 
the Russian Federation by 3.19 years, reaching 62.16 years.  A second major challenge 
will be to halt the spread of tuberculosis in the former Soviet Union.  The reported 
incidence of tuberculosis in the Russian Federation in 2002 was 90 per 100,000 
population, and the Baltic states and the Russian Federation have some of the highest 
documented rates of multidrug-resistant tuberculosis anywhere in the world.  Efforts have 
been undertaken to halt the spread of communicable diseases, but much more remains to 
be done (Rechel and McKee 2004). 
Before proceeding with the scenarios considered in this article, the following Section 2 
discusses the quality of the data used.  Section 3 then describes the methods applied in 
the analytical part of the study.  Section 4 provides the results of the analysis, which are 
discussed in more detail in Section 5.  Finally, Section 6 draws conclusions that are 
relevant to the region and the focus of development assistance.   
2 Data Quality 
Although the government of the Soviet Union and its eastern European satellites created 
extensive systems of vital registration, it cannot be assumed that health data for Eastern 
Europe and Central Asia are now of uniformly high quality.  A major problem in some 
countries is the absence of accurate population data.  Since 1989, wars and conflicts, 
combined with economic and social turmoil and the opening of borders, have triggered 
large-scale population movements that have often remained poorly quantified.   
Another problem is that health information systems deteriorated or, in some cases, 
collapsed.  A recalculation of life expectancy in Georgia concluded that official data may 
overestimate life expectancy at birth by as much as 8 years (Badurashvili, McKee et al. 
2001). 
Shifting definitions is a further problem.  A study in Croatia showed that official 
mortality data were unreliable for the 1990s, with one of the main problems that the 
population denominator used before 1996 included not only people living in Croatia, but 
also Croatian citizens living permanently abroad (Bozicevic, Oreskovic et al. 2001).   
Particularly serious concerns have been raised about the quality of data on infant and 
child mortality, in particular for Central Asia and the Caucasus.  This can be illustrated 
by the case of Tajikistan where the reported rate of child mortality in 1999 is 1.16 
compared to an EU-15 level of 1.02 per 1,000 live births in the same year, while the 
figure given for 1990 was 20.56.  It is apparent that, given the sequelae of civil war in 
Tajikistan and the breakdown in many governmental functions, including presumably 
vital registration, the recent data on child mortality must be treated with considerable 
skepticism. 
More detailed studies in these countries have identified three main factors that may 
contribute to the underestimation of childhood mortality (UNICEF 2001; McKee, Healy 
et al. 2002; Aleshina and Redmond 2003; Government of Tajikistan 2003; UNICEF 
2003).  The first is that in many countries of Central Asia and the Caucasus, the Soviet 
definition of live birth is still in use.  This reclassifies many very premature babies as 
stillbirths, with the effect of reducing the infant mortality rate by 22-25% (Aleshina and 
Redmond 2003).  Armenia, Georgia and Kyrgyzstan have recently adopted the WHO 
definition of a live birth, but in practice implementation has been only partial.  In the 
remaining countries of Central Asia and the Caucasus, the Soviet definition is still in use 
(Aleshina and Redmond 2003).  The second factor contributing to official underestimates 
is the misreporting of births and infant deaths by medical staff.  The third factor 
contributing is that births and deaths of children are not reported by parents to the 
authorities, due to fees for registration.  In Kazakhstan, Kyrgyzstan and Tajikistan, fees 
for registration have been abolished in the last two years, but in Georgia there are still 
fees for the registration of births.  Where mothers are not in a registered marriage, the 
charge is doubled, resulting in an increased risk of under-registration of children of single 
mothers (Aleshina and Redmond 2003). 
In view of these problems with the quality of data, UN organizations such as UNICEF 
and the World Bank have produced alternative data sets on infant and child mortality, 
using models that include data from surveys and other sources.  As a consequence, the 
health-related Millennium Development targets that were established on the basis of 
estimates of 1990 levels, as well as measurement of progress towards these targets by 
World Bank and UNDP are based on World Bank estimates of infant and child mortality 
rather than on national registration data. 
Although estimates based on survey data are likely to reflect the real infant mortality 
rates in Central Asia and the Caucasus better than national registration data, they too have 
limitations.  Surveys are associated with a number of errors that limit their capacity to 
gauge current levels of infant and child mortality and even more so when assessing infant 
and child mortality up to ten years previously.  Where indirect estimates of infant 
mortality are used, as in the Multiple Indicator Cluster Surveys, extra potential sources of 
error are introduced (Aleshina and Redmond 2003).   
The methods used to estimate childhood mortality from these data have been neither 
consistent nor transparent.  In effect, different UN organizations are using different 
datasets and it is often unclear, or at least very difficult to discover, what data were used 
and how the resulting figures were generated.  Interpretation and subjective judgments 
play a considerable part in production of the estimates.  The uncertainties associated with 
surveys and survey-based estimates mean that surveys can only ever be partial solutions 
to the problem of incomplete vital registration.   
A more fundamental drawback when using World Bank data is that some indicators, such 
as maternal mortality rates in 1990, are missing from the published tables and others, 
such as infant mortality, are incomplete.  If the intention is to track changes, WHO, 
recording national registration data supplied by the countries, is the only complete source 
of the data required. However, since the quality of data in many countries is either poor 
or doubtful, the data have limited usefulness for serious policy decisions.   
As long as national registration is incomplete, the exact levels of childhood mortality in 
Central Asia and the Caucasus will remain unknown.  In this context, the analysis of the 
impact of the health-related Millennium Development Goals on these countries in the 
current study was confronted with the choice of whether to use national registration data 
or survey-based estimates.  It was decided to use both datasets in two parallel 
calculations.  National registration data were used for all scenarios considered in this 
study.  Where, in addition, survey-based estimates by the World Bank were available for 
the countries of Central Asia and the Caucasus, as was the case for infant and child 
mortality, an additional analysis based on these estimates was undertaken.  Although 
neither of these two approaches may be entirely accurate, the aim was to make the best 
use of currently available data. 
3 Methods 
This analysis is primarily based on population and mortality data by age, sex and cause of 
death, as reported by national statistical offices to the WHO in June 2003.  The latest 
updates by WHO at this time were from 10 February 2003 for the population data and 
from 31 December 2002 for the mortality data.  Using these data, life tables were 
calculated based on standard methods (Chiang 1968), as was done in the earlier study of 
the Russian Federation (Lock, Andreev et al. 2002).  The analysis covered all countries of 
the World Bank’s Europe and Central Asia region (here designated as “Eastern Europe 
and Central Asia”), with the exceptions of Bosnia and Herzegovina, Serbia and 
Montenegro and Turkey, for which no recent population or mortality data were available. 
Using the official data reported by the countries to WHO, life expectancies were 
tabulated.  The effects on life expectancy at birth were then calculated for the following 
four scenarios: 
1) achieving MDG targets for infant, child and maternal mortality;  
2) reducing infant, child and maternal mortality to EU-15 levels;  
3) reducing infant, child and maternal mortality to the lowest sub-regional levels;  
4) keeping infant, child and maternal mortality constant and reducing deaths from 
cardiovascular disease and external causes of death to EU-15 levels. 
Where regional and sub-regional averages are shown they have been population-
weighted.  In countries that have already achieved or over-achieved the target levels of 
the scenarios, the lower of the two figures was taken as the target, as it was assumed, for 
present purposes, that none of these countries (all among the most advanced in the 
region) would relinquish their achievements.  As maternal mortality ratios are expressed 
in terms of numbers of live births it was necessary to adapt them for use in the life tables.  
This was done by setting the target as the current death rate from maternal causes in the 
age group 15-49 times the ratio of the target maternal mortality rate per 100,000 live 
births to the current rate.  In effect this meant assuming that the current live birth rate 
would be unchanged.   
As has been noted previously, achievement of Millennium Development Goal 6 
(combating HIV/AIDS, malaria, and tuberculosis) has not been included in the analysis, 
since the impact of these diseases on life expectancy at birth is still relatively small.  
However, it is important to recognize that this will change dramatically in the near future. 
Scenario 1 explored the impact on life expectancy at birth of reaching the MDGs for 
infant, child and maternal mortality.  The MDGs consider progress from a designated 
baseline, the year 1990.  Infant, child, and maternal mortality rates for 1990 were taken 
from the January 2003 version of the WHO HFA database to establish the MDG targets 
for 2015.  The most recent available data for infant, child, and maternal mortality from 
the WHO HFA database were used to analyze the effects on life expectancy, if these 
indicators could be reduced to MDG levels. 
In Scenario 2, life tables were recalculated on the basis of achieving the most recent EU-
15 levels for infant, child and maternal mortality, showing the effects on life expectancy. 
In Scenario 3, infant, child and maternal mortality of each country were reduced to the 
lowest levels achieved within four sub-regional groupings: 
1) Former communist EU candidate countries (status of 2003);  
2) South Eastern Europe excluding EU candidates Bulgaria and Romania (Albania, 
Croatia and Macedonia); 
3) Central Asia and Caucasus;  
4) The remaining countries of the former Soviet Union (Belarus, Moldova, Russia, 
Ukraine).  
Scenario 4 kept infant, child and maternal mortality rates constant, and reduced the 
deaths from cardiovascular disease and external causes of deaths to the current EU-15 
average. 
Because of the known problems with data from Central Asia and the Caucasus, the 
analyses for these countries were undertaken separately in the first three scenarios for 
infant and child mortality, using both national vital registration data as reported to WHO 
and World Bank estimates of infant and child mortality.  In the latter case, World Bank 
estimates of infant and child mortality rates were substituted in the life tables.  For 
Scenario 1, the targets for Goal 4 were established on the basis of World Bank estimates 
of infant and mortality rates for 1990.  For Scenario 3, the lowest sub-regional rates of 
infant and child mortality were similarly established on the basis of World Bank 
estimates. 
4 Results  
As the first step of the analysis, life expectancies were tabulated for the countries of 
Eastern Europe and Central Asia, using national registration data supplied to the WHO.  
In the case of Central Asia and the Caucasus, this analysis was complemented by an 
adjustment of life tables with World Bank estimates on infant and child mortality.  
Because these estimates show much higher values than the official data reported to the 
WHO, life expectancies in all countries of this region would be considerably lower if the 
World Bank’s estimates of infant and child mortality rates are assumed to be more 
accurate.  Figure 1 shows the results of recalculations of life tables according to different 
estimates of infant and child mortality.  The difference is most dramatic for Tajikistan, 
where life expectancy would be reduced by 13.4 years.   
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Using the calculated life expectancies, the impact of the different scenarios on life 
expectancy was then analyzed.  For the countries of Central Asia and the Caucasus, two 
complimentary analyses were undertaken, the first based on national registration data, the 
second based on World Bank estimates of infant and child mortality rates. 
The results of the four scenarios are summarized in Table 1 and 2 and Figure 2.  In the 
whole of Eastern Europe and Central Asia, as well as in all four sub-regions and in most 
individual countries, the gain in life expectancy was by far greatest in Scenario 4.  
Reducing mortality levels from cardiovascular disease and external causes of death to 
EU-15 levels would result in an average gain of 7.75 years.   
The reductions in infant, child and maternal mortality in Scenarios 1-3, on the other hand, 
would result in markedly lower gains in life expectancy.  Scenario 1 (reaching the MDGs 
for infant, child and maternal mortality) resulted in an average ECA gain of between 0.68 
and 1.24 years.  Scenario 2 (reaching EU-15 levels for infant, child and maternal 
mortality) would result in an average gain of 0.85-1.57 years, while Scenario 3 (reaching 
the lowest sub-regional levels of infant, child and maternal mortality) would result in an 
average gain of 0.58-1.09 years.   
In Central Asia and the Caucasus, gains in the first three scenarios were considerably 
higher, when the calculations were based on World Bank estimates of infant and child 
mortality.  In this case, average sub-regional gains would be 4.04 years in Scenario 1, 
5.60 years in Scenario 2 and 4.02 years in Scenario 3.  At a country level, Tajikistan 
would gain most (12.29 years) in Scenario 2. 
Several countries of the former Soviet Union stand to make considerable gains under 
Scenario 4 (based on national registration data).  These countries are the Russian 
Federation (10.09 years), Turkmenistan (9.70 years), Ukraine (8.67 years), Kazakhstan 
(8.63 years), Lithuania (7.47 years) and Latvia (7.20 years).   
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5 Discussion 
5.1 Implications for systems of data collection 
One of the major issues this study faced was the scale of the problems with existing data 
on which to judge progress towards identified targets in many countries.  As noted above, 
there is currently no consensus on the true scale of infant and child mortality rates in 
Central Asia and the Caucasus.  Estimates differ not only between national governments 
and international organizations, but between UN organizations themselves.  This 
ultimately threatens the credibility of the estimates.  International agencies should publish 
the basis on which they have derived their estimates for key health indicators and should 
initiate a process to achieve consensus on the best estimates for each country.   
It is especially important to involve national governments in this dialogue, thus securing 
national ownership of estimates generated by international organizations and 
strengthening the case for improvements in national vital registration.  It is essential that 
the governments of Central Asia and the Caucasus recognize that life expectancies are 
likely to be dramatically lower than official data suggest.   
Governments and international agencies should place a high priority on strengthening 
systems for vital registration.  As a first step it will be necessary to address the main 
factors that contribute to the discrepancies between official and survey data in Central 
Asia and the Caucasus.  First, it is important that all countries adopt and implement fully 
the WHO definition of a live birth rather than the Soviet one.  Second, training for health 
care staff is required to reduce misreporting of infant deaths.  This will need to be 
accompanied by the abolition of incentives that lead staff to underreport infant mortality, 
such as the systems of control and sanctions that inhibit open discussion of adverse 
events.  It will also require the creation of suitable incentives to increase the accuracy of 
reporting.  Third, to ensure the reporting of births and deaths by parents, registration fees 
should be abolished where they still exist, as in Georgia.  There are also many examples 
of how registration can be linked to access to benefits (financial and otherwise) to create 
positive incentives to improve vital registration.  However it should also be recognized 
that some countries in Central Asia or the Caucasus may be reluctant to improve the 
accuracy of their data, as high official infant mortality rates would portray their countries 
in a negative light.   
While national registration is still incomplete, it is possible to improve the quality of 
survey data.  One way is by increasing the sample sizes, consequently narrowing 
confidence intervals and providing more accurate estimates, as well as by increasing the 
number of surveys, taking into account the problem of selective non-response of 
interviewees.  This is most acute in the countries of Central Asia and the Caucasus, but 
also concerns other countries in Eastern Europe and Central Asia, where concerns about 
the quality of data have been raised, but where hardly any surveys have been undertaken 
so far.   
5.2 Policy choices and combination of indicators 
Obviously, health targets and policy interventions need to be adapted to the individual 
country context.  Perhaps the most important message of this study is that simply 
following global development targets will not be the best way to enhance the health of 
the populations in Eastern Europe and Central Asia.  The reason for this is that the burden 
of disease and mortality varies widely between countries and generally differs markedly 
from the patterns observed in developing countries.   
The eight countries of Central Asia and the Caucasus exhibit very high under-5 and 
maternal mortality rates.  It is those countries that would benefit most from achieving the 
MDGs as this will lead to a substantial improvement in overall health.  In those countries 
where infant, under-5 and maternal mortality remain high there is a continuing need to 
direct resources to policies that will reduce them.  This is likely to include strengthening 
basic social services and primary health care although, given the need to reflect local 
context, it will also be important not simply to transfer uncritically policies from other 
parts of the world.  Instead, international agencies, bilateral donors and global 
foundations should support primary research into the causes of adverse health outcomes 
among these populations.   
In addition to high rates of childhood mortality, some of the countries of Central Asia and 
the Caucasus are at the same time struggling with staggering rates of adult mortality.  
One of the main findings that emerged from this study is that the health-related MDGs 
need to be adapted to Eastern Europe and Central Asia, so that they include adult 
mortality.  This is particularly true of the countries of the former Soviet Union, but also 
of other countries of Eastern Europe and Central Asia.  A potential average gain of 7.75 
years in life expectancy at birth, when reducing mortality from cardiovascular diseases 
and external causes of death to EU-15 levels, simply cannot be ignored. 
There are various ways in which adult mortality could be included in the MDGs.  One 
way of doing so would be to include additional health indicators under Target 8 of Goal 
6.  At the most general level, life expectancy at birth could be used as an additional 
indicator.  More specifically, major causes of adult mortality could be used as indicators 
of development.  Although there are problems with the accuracy of mortality data in 
some countries of the region, these inaccuracies are unlikely to be any greater than those 
for traditional MDG indicators, and may even be less.  Two additional indicators 
important for Eastern Europe and Central Asia are those used in this study, namely 
mortality rates from cardiovascular disease and external causes of death.   
5.3 Need for development assistance 
It is not necessary to wait for mortality levels to change to assess progress.  Instead, it is 
possible to intervene to address the main risk factors for cardiovascular disease, tracking 
changes that will appear before mortality declines.  Cardiovascular disease arises as a 
consequence of a complex set of risk factors, including tobacco use, physical inactivity 
and unhealthy diet and although the precise contribution of different factors in this region 
differs from that in western populations (for example, the very low levels of dietary anti-
oxidants and the consequences of episodic heavy drinking), changes in the prevalence of 
key risk factors could be used as additional indicators under Target 8 of Millennium 
Development Goal 6.  So far, however, available data on the prevalence of relevant risk 
factors is very limited.  Again, the gathering of more accurate data would help to direct 
policy responses to where they are most needed.   
Appropriate policy interventions to reduce the high levels of adult mortality must include 
the strengthening of public health services, with more emphasis on health promotion and 
disease prevention.  Concerted public health efforts are in particular required to 
counteract the tobacco epidemic which is spreading in Eastern Europe and Central Asia.  
The spread of tuberculosis, including multidrug-resistant tuberculosis, and HIV/AIDS are 
other strong reminders of the need for such improvements in public health programs, 
including health promotion activities.  The high rates of external causes of death, in 
particular among infants and children, call for concerted efforts to prevent injuries, 
especially during childhood. 
In general, international assistance should be focused on the countries in Eastern Europe 
and Central Asia with the largest burden of disease and premature mortality.  As this 
study has shown, this concerns not only infant, child and maternal mortality, but also 
adult mortality.  In this sense, the current study highlights where the need for 
development assistance in the health sector is greatest.  The allocation of resources to the 
countries with the highest burden of mortality and disease could also be an incentive to 
improve vital registration systems.   
6 Conclusion 
A policy aimed at reducing mortality levels from cardiovascular disease and external 
causes of death to the levels in the EU-15 emerges as having the greatest potential to 
impact on life expectancy at birth, outweighing potential gains that might be achieved 
when reducing infant and child mortality.  In summary, it can therefore be concluded that 
this study has made the case for complementing the MDGs in Eastern Europe and Central 
Asia with another set of goals or indicators that take into account adult mortality, while at 
the same time showing the benefits of reducing infant and child mortality in Central Asia 
and the Caucasus.  In order to judge progress towards identified targets, governments and 
international agencies need to place a high priority on strengthening systems for vital 
registration, in particular in the countries of Central Asia and the Caucasus.   
As already noted, Millennium Development Goal 6 could be used to complement the 
traditional MDGs, focusing on reversing the spread of HIV/AIDS and reducing the 
incidence of malaria and “other major diseases”.  Yet, the only other disease specified in 
the related indicators in addition to HIV/AIDS and malaria is tuberculosis.  Nevertheless, 
the use of the term “other major diseases” in the Goal makes it possible to include other 
major diseases that are more relevant in a specific country or regional context.  This 
might leave countries room within the framework of the MDGs to identify and tackle the 
diseases that cause the most damage to their populations, offering an opportunity for 
dialogue between governments and international agencies to operationalize appropriate 
targets.  In Eastern Europe and Central Asia, these targets should include cardiovascular 
diseases and external causes of death, including the prevention of accidents, suicides and 
homicides.  Both cardiovascular diseases and external causes of death are much more 
prevalent among males than among females and policies addressing their causes need to 
take account of this gender dimension. 
This study highlights the great variety among the countries of Eastern Europe and Central 
Asia.  As the potential gains in life expectancy indicate, levels of infant, child and 
maternal mortality, as well as of mortality from cardiovascular diseases and external 
causes, vary widely among the different countries of the region.  At one extreme is 
Slovenia, which would achieve almost no gain in life expectancy in the first three 
scenarios and only 1.36 years in Scenario 4.  At the other end are Tajikistan, gaining 
12.29 years in Scenario 2, and Turkmenistan, gaining 9.70 years in Scenario 4.  
Obviously, these countries need to adopt different strategies to improve the health of their 
populations.  This illustrates that appropriate policy interventions need to be developed at 
a country level and should not slavishly follow global development goals.  It would 
clearly be mistaken to establish common goals for all countries of Eastern Europe and 
Central Asia. 
Going beyond Eastern Europe and Central Asia, the study allows two more general 
conclusions.  The first concerns adult mortality.  The importance of non-communicable 
diseases and external causes of death is more obvious in the countries of Eastern Europe 
and Central Asia because vital registration systems, while imperfect, are much better than 
in other countries at comparable levels of development.  However their importance is not 
confined to this region.  It is often forgotten that non-communicable diseases and injuries 
account for more than half of all lost years of healthy life in developing countries (UNDP 
2003).  Mortality from these causes of death could be used as additional indicators of 
progress towards the MDGs, where data are available.  This view has now been endorsed 
by senior WHO experts, calling for the inclusion of adult mortality and morbidity in the 
MDGs (Kowal and Lopez 2003).   
The second conclusion concerns life expectancy.  Life expectancy is not only the most 
general summary measure of mortality in a population, but also a measure of social 
development.  An increase in life expectancy should therefore be a global development 
goal in itself.  Improvements in life expectancy have previously been used as UN 
development goals.  A UN General Assembly resolution in 1980 called for raising life 
expectancy in all countries to 60 years by 2000.  In 124 of the 173 countries that fell 
below that level this goal has been achieved (UNDP 2003). 
As was noted previously, this study has been limited to the analysis of the potential 
impact of reaching MDGs 4 and 5.  Although mortality from HIV/AIDS is still 
comparatively low, this is likely to change in the near future.  Studies modeling the future 
impact of HIV in this region exist but they are limited by the lack of contextually valid 
data on, for example, exposure to risk in the countries involved.  International agencies 
should continue their efforts to develop models of the future impact of HIV and 
tuberculosis in the region, paying particular attention to the complexities of the co-
existence of HIV and multi-drug resistant tuberculosis, exploring various scenarios and 
policy responses, and linking this information to Goal 6 so as to contribute to the 
discussion of the appropriateness of the MDGs to Eastern Europe and Central Asia. 
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Appendix: The Millennium Development Goals 
 
Goal 1:  Eradicate extreme poverty and hunger 
Goal 2:  Achieve Universal Primary Education 
Goal 3: Promote Gender Equality and Empower Women 
Goal 4*: Reduce child mortality 
Target 5: Reduce by two-thirds, between 1990 and 2015, the under-five mortality rate 
Indicators:  Under-five mortality rate 
 Infant mortality rate 
 Proportion of one-year-old children immunized against measles 
Goal 5*: Improve maternal health 
Target 6: Reduce by three-quarters, between 1990 and 2015, the maternal mortality rate 
Indicators: Maternal mortality ratio 
 Proportion of births attended by skilled health personnel 
Goal 6*: Combat HIV/AIDS, malaria and other diseases 
Target 7: Have halted by 2015 and begun to reverse the spread of HIV/AIDS 
Indicators: HIV prevalence among 15- to 24-year-old pregnant women 
 Contraceptive prevalence rate 
 Number of children orphaned by HIV/AIDS 
Target 8: Have halted by 2015 and begun to reverse the incidence of malaria and other 
major diseases 
Indicators: Prevalence and death rates associated with malaria 
Proportion of population in malaria-risk areas using effective malaria 
prevention and treatment measures 
 Prevalence and death rates associated with tuberculosis 
 Proportion of tuberculosis cases detected and cured under DOTS 
 
Goal 7: Ensure environmental sustainability 
 
Goal 8: Build a global partnership for development 
 
Source:  World Bank Group.  http://www.developmentgoals.org/About_the_goals.htm. 
Accessed on March 12, 2004. 
*: Examined in this study. 
 
 Figure 1 Life Expectancies in Central Asia and the Caucasus according to 
different estimates of infant and child mortality 
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Note: Data refer to latest available years 
 
Figure 2 Gain in Life Expectancy According to the Different Scenarios: 
Regional and Sub-regional averages 
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Note: (1) based on World Bank data on infant and child mortality in Central Asia and Caucasus 
 
 Table 1  Gain in Life Expectancy According to the Different Scenarios 
 
Scenario 1: 
Reaching 
MDGs 4 and 5 
Scenario 2: 
Reaching EU-15 
levels 
Scenario 3: 
Reaching best 
sub-regional 
levels 
Scenario 4: 
Reaching EU-15 
levels for CVD 
and external 
causes 
Former communist EU candidate countries (status of 2003) 
Bulgaria 0.76 0.77 0.88 6.57 
Czech Republic 0.07 0 0.05 3.50 
Estonia 0.39 0.37 0.48 6.72 
Hungary 0.27 0.26 0.36 4.29 
Latvia 0.49 0.48 0.09 7.20 
Lithuania 0.45 0.34 0.45 7.47 
Poland 0.24 0.25 0.36 3.30 
Romania 0.73 1.12 1.22 6.85 
Slovakia 0.40 0.31 0.42 4.65 
Slovenia 0.12 0 0.02 1.36 
Sub-regional average 0.39 0.46 0.55 4.75 
South Eastern Europe 
Albania 0.20 0.76 0.55 3.10 
Croatia 0.31 0.19 0 3.54 
Macedonia 0.24 0.65 0.40 4.84 
Sub-regional average 0.26 0.47 0.27 3.67 
Remaining countries of the former Soviet Union 
Belarus 0.48 0.42 0 7.52 
Moldova 0.90 1.07 0.64 7.36 
Russian Federation 0.79 0.88 0.48 10.09 
Ukraine 0.67 0.65 0.26 8.67 
Sub-regional average 0.75 0.81 0.41 9.58 
 
Overall ECA average 0.68 0.85 0.58 7.75 
Overall ECA average (1) 1.24 1.57 1.09  
Note: (1) based on World Bank data on infant and child mortality in Central Asia and Caucasus; 
data refer to latest available years; no recent data available for Bosnia and Herzegovina, Serbia 
and Montenegro and Turkey 
 
Table 2 Gain in Life Expectancy According to the Different Scenarios (Central Asia and Caucasus) 
 National registration data World Bank data 
 
Scenario 1: 
Reaching MDGs 4 
and 5 
Scenario 2: 
Reaching EU-
15 levels 
Scenario 3: 
Reaching best 
sub-regional 
levels 
Scenario 4: 
Reaching EU-
15 levels for 
CVD and 
external causes 
Scenario 1: 
Reaching 
MDGs 4 and 5 
Scenario 2: 
Reaching EU-
15 levels 
Scenario 3: 
Reaching best 
sub-regional 
levels 
Armenia 0.86 1.02 0.58 4.36 1.38 2.38 0.72 
Azerbaijan 0.73 1.31 0.89 6.47 3.98 5.71 4.48 
Georgia 0.57 0.63 0.03 6.39 1.92 2.29 0.07 
Kazakhstan 1.02 1.39 1.01 8.63 5.05 5.74 4.41 
Kyrgyzstan 1.44 1.99 1.59 5.67 2.41 3.82 2.35 
Tajikistan 0.48 0.82 0.68 5.19 7.97 12.29 10.55 
Turkmenistan 2.05 3.05 2.69 9.70 3.37 5 3.67 
Uzbekistan 0.97 1.89 1.43 7.98 3.72 5.39 3.62 
Sub-regional average 0.98 1.58 1.18 7.37 4.04 5.60 4.02 
Note: Data refer to latest available years 
 
 
 
